Osaic Holdings’s Immix Biopharma IMMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.2K Hold
4,000
﹤0.01% 5618
2026
Q1
$36.4K Buy
+4,000
New +$29.4K ﹤0.01% 5442
2024
Q4
Sell
-950
Closed -$1.42K 7525
2024
Q3
$1.42K Hold
950
﹤0.01% 6736
2024
Q2
$1.88K Buy
+950
New +$2.18K ﹤0.01% 6616
2024
Q1
Sell
-350
Closed -$2.42K 7294
2023
Q4
$2.42K Hold
350
﹤0.01% 6471
2023
Q3
$1.2K Hold
350
﹤0.01% 6777
2023
Q2
$941 Hold
350
﹤0.01% 6890
2023
Q1
$637 Hold
350
﹤0.01% 7079
2022
Q4
$1K Hold
350
﹤0.01% 6888
2022
Q3
$0 Hold
350
﹤0.01% 7373
2022
Q2
$1K Hold
350
﹤0.01% 7085
2022
Q1
$1K Buy
+350
New +$1.3K ﹤0.01% 7054

Other funds holding IMMX

Osaic Holdings's IMMX Position: Q2 2026 in Review

Osaic Holdings held its Immix Biopharma (IMMX) position steady in Q2 2026 at 4,000 shares worth $41.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5618.

Osaic Holdings first reported a position in IMMX in Q1 2022 and has held it in 12 quarters since. 109 funds tracked by Wall St. Rank hold IMMX as of Q2 2026.

  • Osaic Holdings held 4,000 shares of Immix Biopharma worth $41.2K as of Q2 2026.
  • Osaic Holdings left its Immix Biopharma share count unchanged in Q2 2026.
  • Immix Biopharma made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5618 holding.
  • Osaic Holdings first reported a position in Immix Biopharma in Q1 2022 and has held it in 12 quarters since.
  • 109 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.